tirzepatide research chemical | CAS#2023788-19-2 | GIP/GLP-1 Receptor Agonist Tirzepatide 10MG Research Peptide |

The retail price of brand-name Wegovy can exceed $1,300 per month without insurance

Mounjaro contains tirzepatide, which activates both GIP and GLP-1 receptors two gut hormone pathways involved in appetite regulation and blood sugar control

[1] Wegovy follows a more gradual escalation schedule over 1620 weeks: Weeks 14 : 0.25 mg once weekly Weeks 58 : 0.5 mg once weekly Weeks 912 : 1 mg once weekly Weeks 1316 : 1.7 mg once weekly Week 17 onward : 2.4 mg once weekly (maintenance dose) If patients do not tolerate a dose during titration, the prescribing information allows for delaying dose escalation for additional weeks

Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023